Evidence map›Paper›PMID 25447996›Full record

ArticleCurrent biology : CB2014

A Golgi-localized pool of the mitotic checkpoint component Mad1 controls integrin secretion and cell migration.

Jun Wan, Fen Zhu, Lauren M Zasadil, Jiaquan Yu, Lei Wang, Adam Johnson, Erwin Berthier, David J Beebe, Anjon Audhya, Beth A Weaver

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Aneuploidy: Cancer strength or vulnerability?International journal of cancer · 2019
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jun WanDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, USA; Physiology Training Program, University of Wisconsin, Madison, WI 53705, USA.
Fen ZhuDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, USA.
Lauren M ZasadilDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, USA; Molecular and Cellular Pharmacology Training Program, University of Wisconsin, Madison, WI 53705, USA.
Jiaquan YuDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI 53705, USA.
Lei WangDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, WI 53705, USA.
Adam JohnsonDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, WI 53705, USA.
Erwin BerthierDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI 53705, USA.
David J BeebeDepartment of Biomedical Engineering, University of Wisconsin, Madison, WI 53705, USA; Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA.
Anjon AudhyaDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, WI 53705, USA; Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA.
Beth A WeaverDepartment of Cell and Regenerative Biology, University of Wisconsin, Madison, WI 53705, USA; Carbone Cancer Center, University of Wisconsin, Madison, WI 53705, USA. Electronic address: baweaver@wisc.edu.
University of Wisconsin–Madison · USUniversity of Wisconsin Carbone Cancer Center · US

Funding

Training in Cancer Biology Training GrantT32CA009135 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SUGDEN, WILLIAM M. · 1985 to 2024
$10.4M
Molecular Mechanisms that Regulate Lysosomal Protein TransportR01GM088151 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI AUDHYA, ANJON · 2010 to 2019
$3.0M
Understanding cell migration through microscale in vitro modelsR01EB010039 · NIBIB · UNIVERSITY OF WISCONSIN-MADISON · PI BEEBE, DAVID J, HUTTENLOCHER, ANNA · 2011 to 2014
$1.7M
Mitosis, Aneuploidy and CancerR01CA140458 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI WEAVER, BETH A · 2011 to 2015
$1.5M
NCI NIH HHS R01 CA140458NCI NIH HHS R01CA140458NCI NIH HHS T32 CA009135NIBIB NIH HHS R01 EB010039NIBIB NIH HHS R01EB010039NIGMS NIH HHS R01 GM088151NIGMS NIH HHS R01GM088151
6 · The paper itself

Abstract

Mitotic arrest deficient 1 (Mad1) plays a well-characterized role in the major cell-cycle checkpoint that regulates chromosome segregation during mitosis, the mitotic checkpoint (also known as the spindle assembly checkpoint). During mitosis, Mad1 recruits Mad2 to unattached kinetochores, where Mad2 is converted into an inhibitor of the anaphase-promoting complex/cyclosome bound to its specificity factor, Cdc20. During interphase, Mad1 remains tightly bound to Mad2, and both proteins localize to the nucleus and nuclear pores, where they interact with Tpr (translocated promoter region). Recently, it has been shown that interaction with Tpr stabilizes both proteins and that Mad1 binding to Tpr permits Mad2 to associate with Cdc20. However, interphase functions of Mad1 that do not directly affect the mitotic checkpoint have remained largely undefined. Here we identify a previously unrecognized interphase distribution of Mad1 at the Golgi apparatus. Mad1 colocalizes with multiple Golgi markers and cosediments with Golgi membranes. Although Mad1 has previously been thought to constitutively bind Mad2, Golgi-associated Mad1 is Mad2 independent. Depletion of Mad1 impairs secretion of α5 integrin and results in defects in cellular attachment, adhesion, and FAK activation. Additionally, reduction of Mad1 impedes cell motility, while its overexpression accelerates directed cell migration. These results reveal an unexpected role for a mitotic checkpoint protein in secretion, adhesion, and motility. More generally, they demonstrate that, in addition to generating aneuploidy, manipulation of mitotic checkpoint genes can have unexpected interphase effects that influence tumor phenotypes.

Indexed as

Cell Cycle CheckpointsCell Cycle ProteinsCell MovementCytoplasmGolgi ApparatusHeLa CellsHumansIntegrinsMad2 ProteinsNuclear ProteinsSignal TransductionCell Cycle ProteinsIntegrinsMAD1L1 protein, humanMAD2L1 protein, humanMad2 ProteinsNuclear Proteins

Identifiers

PMID25447996
PMCPMC4254593
OpenAlexW2064647629

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.